Neil A. Ettinger
Expertise in
29
conditions

Dr. Neil A. Ettinger

Physician Specialists Of St Lukes LLC
Chesterfield, MO
Expertise in
29
conditions
Specialties:Pulmonary Medicine | Intensive Care Medicine | Pain Medicine
Accepting New Patients
Offers Telehealth
Expertise in
29
conditions
OverviewInsuranceLocationsClinical Research

Overview

Neil Ettinger is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Chesterfield, Missouri. Dr. Ettinger is highly rated in 29 conditions, according to our data. His top areas of expertise are Pulmonary Fibrosis, Acute Interstitial Pneumonia, Pneumonia, Advanced Bronchoscopy, and Gastrostomy. Dr. Ettinger is currently accepting new patients.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Intensive Care Medicine
Pain Medicine
Licenses
Critical Care Medicine in MO
Hospital Affiliations
St Luke's Des Peres Hospital
St Lukes Hospital
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  UnitedHealthcare
  •  Humana

Locations

PHYSICIAN SPECIALISTS OF ST LUKES LLC
232 S Woods Mill Rd Sleep Medicine, Chesterfield, MO 63017
314-205-6030

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2024
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
Enrollment Status: Terminated
Publish Date: July 27, 2023
Intervention Type: Combination product
Study Drug: INOpulse
Study Phase: Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

6 Total Publications

Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'.
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'.
Journal: American journal of respiratory and critical care medicine
Published: January 04, 2024
Similar Doctors
Expertise in
7
conditions
Dr. Thomas M. Siler
Pulmonary Medicine | Sleep Medicine | Intensive Care Medicine
Expertise in
7
conditions
Dr. Thomas M. Siler
Pulmonary Medicine | Sleep Medicine | Intensive Care Medicine

Ssm Health Care St Louis

1015 Bowles Ave, 
Fenton, MO 
 (8.6 mi)
636-496-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Thomas Siler is a Pulmonary Medicine specialist and a Sleep Medicine provider in Fenton, Missouri. Dr. Siler is highly rated in 7 conditions, according to our data. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Obstructive Sleep Apnea, and Neurosarcoidosis. Dr. Siler is currently accepting new patients.

Expertise in
22
conditions
Dr. Bobby H. Shah
Pulmonary Medicine | Intensive Care Medicine
Expertise in
22
conditions
Dr. Bobby H. Shah
Pulmonary Medicine | Intensive Care Medicine

Cardio-Pulmonary Associates, LLC

222 S Woods Mill Rd, 310n, 
Chesterfield, MO 
 (0.1 mi)
314-682-3630
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Bobby Shah is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Chesterfield, Missouri. Dr. Shah is highly rated in 22 conditions, according to our data. His top areas of expertise are Lung Nodules, Pneumonia, Lung Metastases, and Pleural Effusion. Dr. Shah is currently accepting new patients.

Expertise in
21
conditions
Dr. Adrian A. Shifren
Pulmonary Medicine
Expertise in
21
conditions
Dr. Adrian A. Shifren
Pulmonary Medicine

Washington University

10 Barnes W Dr, 
Saint Louis, MO 
 (2.5 mi)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Adrian Shifren is a Pulmonary Medicine provider in Saint Louis, Missouri. Dr. Shifren is highly rated in 21 conditions, according to our data. His top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, and Idiopathic Pulmonary Fibrosis. Dr. Shifren is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile